Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M201Revenue (TTM) $M1.8Net Margin (%)-2,346.5Altman Z-Score2.7
Enterprise Value $M141EPS (TTM) $-1.7Operating Margin %-2,269.8Piotroski F-Score2
P/E(ttm)--Beneish M-Score1.3Pre-tax Margin (%)-2,346.5Higher ROA y-yY
Price/Book3.210-y EBITDA Growth Rate %--Quick Ratio9.3Cash flow > EarningsY
Price/Sales1085-y EBITDA Growth Rate %--Current Ratio9.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-42.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-53.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M24.9ROIC % (ttm)-4,795.8Gross Margin Increase y-yN

Gurus Latest Trades with OCUL

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

OCUL is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


OCUL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sawhney AmarpreetPresident and CEO, 10% Owner 2016-12-15Buy45,300$7.853.06view
Sawhney AmarpreetPresident and CEO, 10% Owner 2016-06-09Buy10,000$6.720.75view
Sawhney AmarpreetPresident and CEO, 10% Owner 2015-11-17Buy10,000$8.25-1.94view
Fortune JamesCOO 2015-09-15Sell9,470$17.16-52.86view
Sawhney AmarpreetPresident and CEO, 10% Owner 2015-09-14Buy15,000$16.5-50.97view
Versant Venture Capital III, L10% Owner 2015-06-15Sell320,000$22-63.23view
Warden Charles MDirector, 10% Owner 2015-06-15Sell320,000$22-63.23view
SVLSF IV, LLC10% Owner 2015-06-10Sell1,119,000$22-63.23view
Versant Venture Capital III, L10% Owner 2015-06-10Sell427,000$22-63.23view
Warden Charles MDirector, 10% Owner 2015-06-10Sell427,000$22-63.23view

Quarterly/Annual Reports about OCUL:

    News about OCUL:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 

    More From Other Websites
    ETFs with exposure to Ocular Therapeutix, Inc. : January 9, 2017 Jan 09 2017
    6 Major FDA Decisions and Biopharma Catalysts Coming in January and February Jan 06 2017
    Ocular (OCUL) Reports Positive Phase III Data on Eye Drug Jan 05 2017
    Ocular Therapeutix™ Announces Additional Successful Results for Phase 3 Clinical Trial of... Jan 04 2017
    Ocular Therapeutix™ Announces Additional Successful Results for Phase 3 Clinical Trial of... Jan 04 2017
    ETFs with exposure to Ocular Therapeutix, Inc. : December 30, 2016 Dec 30 2016
    7 Key FDA Decisions and Catalysts Expected in January and February Dec 30 2016
    How Ocular Therapeutix Inc (OCUL) Stacks Up Against Its Peers Dec 15 2016
    OCULAR THERAPEUTIX, INC Files SEC form 8-K, Other Events Dec 14 2016
    ETFs with exposure to Ocular Therapeutix, Inc. : December 8, 2016 Dec 08 2016
    OCULAR THERAPEUTIX, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Nov 30 2016
    ETFs with exposure to Ocular Therapeutix, Inc. : November 28, 2016 Nov 28 2016
    Ocular Therapeutix, Inc. :OCUL-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016 Nov 23 2016
    OCULAR THERAPEUTIX, INC Financials Nov 17 2016
    Ocular Therapeutix surges 14% on positive early clinical trial results Nov 14 2016
    Ocular Therapeutix™ Announces Successful Topline Results for Both Inflammation and Pain Primary... Nov 14 2016
    Ocular Therapeutix™ Announces Successful Topline Results for Both Inflammation and Pain Primary... Nov 14 2016
    Edited Transcript of OCUL earnings conference call or presentation 9-Nov-16 1:30pm GMT Nov 09 2016
    Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences Nov 09 2016
    Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences Nov 09 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)